https://spacewatch.global/tag/lambdavision/ AN INDEPENDENT PERSPECTIVE ON SPACE Thu, 06 Nov 2025 10:33:55 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.4 https://spacewatch.global/wp-content/uploads/2024/09/SpaceWatchGlobal-Sign-90x90.png https://spacewatch.global/tag/lambdavision/ 32 32 https://spacewatch.global/2025/11/lambdavision-raises-seed-round-to-revolutionize-blindness-treatment-using-space-based-manufacturing/ Thu, 06 Nov 2025 07:00:00 +0000 https://spacewatch.global/?p=68808 LambdaVision, a biotech innovator, has closed a $7M seed funding round towards leveraging microgravity to manufacture its investigational protein-based artificial retina to help patients regain sight lost to retinal degenerative diseases Seven Seven Six and Aurelia Foundry Fund co-led the seed round with additional support from Seraphim Space, providing the company runway into 2027]]> https://spacewatch.global/2025/05/seraphim-space-announce-mission-15-spacetech-accelerator-cohort/ Tue, 20 May 2025 06:00:00 +0000 https://spacewatch.global/?p=65375 Seraphim Space has announced its selection of ten pioneering startups for Mission 15 of its SpaceTech Accelerator. Launched in 2018, the Seraphim program has supported over 120 companies across 30+ countries, playing a vital role in building the infrastructure of the modern space economy. ]]> https://spacewatch.global/2024/07/spacewatchgl-venture-space-5-surprising-trends-in-the-2024-space-tech-vc-landscape/ Mon, 22 Jul 2024 09:00:44 +0000 https://spacewatch.global/?p=56138 Six months into 2024, with just short of $4b in space-tech investments made so far this year, fascinating trends lead the way in VCs’ preference on space-tech investments. SpaceWatch has covered every investment into space-tech by VCs this year, and you can catch up on those articles here – but in the meantime, here are 5 trends to be aware of in the space-tech investing world.]]> https://spacewatch.global/2023/08/spacewatchglobal-summer-reading-the-wonders-of-micro-g-medicine-4/ Fri, 18 Aug 2023 08:00:30 +0000 https://spacewatch.global/?p=50578 As reviewed in Part 3, LambdaVision, based in Farmington, Connecticut, USA, was founded in 2009 by its President and CEO Dr. Nicole Wagner and co-founder chemist Jordan Greco. Dr. Robert Birge, distinguished chair in chemistry at the University of Connecticut, a renowned expert in the incorporation of light-activated proteins into biomolecular electronic and therapeutic applications, is a Member of the Board of Directors of the company.]]> https://spacewatch.global/2023/08/spacewatchgl-summer-reading-the-wonders-of-micro-g-medicine-3/ Fri, 11 Aug 2023 08:00:29 +0000 https://spacewatch.global/?p=50451 Blindness due to retina diseases affects over 200 million people globally, and that number is expected to reach 290 million by 2040. The two most common retina degenerative diseases are called Retinitis Pigmentosa and Age-related Macular Degeneration (AMD). Retinitis Pigmentosa affects one and a half million people globally. It starts with peripheral vision that goes dark, until the person is completely blind. AMD affects in the US alone 30 million people over 55, including 10 million in the blinding stage. AMD starts with central vision that goes dark, until the person is totally blind.]]> https://spacewatch.global/2020/04/space-tango-wins-nasa-utilization-awards-for-leo-commercialization-of-biomedical-applications/ Tue, 14 Apr 2020 05:00:26 +0000 https://spacewatch.global/?p=21517 Kentucky-based Space Tango, a leader in the commercialization of low-Earth orbit (LEO) for discovery and on-orbit manufacturing across a wide range of applications, today announced the award of three projects focused on biomedical application development on the International Space Station (ISS)]]>